Aravax Company
Aravax is an early stage biotechnology company focused on developing the first safe and rapidly effective treatment for peanut allergy.
Founded Date:
2015
Investor Type:
For Profit
Employee Number:
11-50
Funding Status:
Seed
Technology:
Cancer
Last Funding Type:
Seed
Investors Number:
2
Industry:
PharmTech
Headquarters:
Melbourne, Victoria, Australia